TLR2 and retinopathy of prematurity: Because ROP involves altered endothelial cells, abnormal retinal vascularization, and the dysregulation of VEGF expression coupled with ROS-promoting inflammatory cytokines buildup via the activation of TLR2 and 4, targeting TLRs for VEGF realignment in ROP yields an additional favorable target in the prevention and treatment of the pathology [51].